Dr. Xuping Xie, University of Texas Medical Branch
NanoLuc® Luciferase Reporter Viruses
Dr. Xie’s group constructed a NanoLuc® SARS-CoV-2 reporter virus and screened a broad selection of existing anti-infective drugs. They identified several agents, including remdesivir, as potent, selective inhibitors of SARS-CoV-2. They also used the reporter virus to measure neutralizing antibody levels in COVID-19 patients.
![](https://scv10mr-cdnpre-p-cus-00.azureedge.net/-/media/images/resources/articles-and-publications/pubhub/customer-spotlights/xuping-xie-video-poster-800x450.jpg?rev=2ab55a8bcfaf40c7b1d21c87dc549acf&sc_lang=en)
Learn More
NanoLuc® Luciferase: One Enzyme, Endless Capabilities
NanoLuc® Technologies Advance Virology Research